Crossmark

Collateral damage: rhabdomyolysis from concurrent abemaciclib and rosuvastatin use

Crossref DOI link: https://doi.org/10.1007/s10549-025-07845-w

Published Online: 2025-11-21

Published Print: 2026-01

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Kim, Tae Hoon https://orcid.org/0009-0009-3402-9470
Zobi, Ayah

Teplinsky, Eleonora
License Information

Text and Data Mining valid from 2025-11-21

Version of Record valid from 2025-11-21
More Information

Article History

Received: 20 September 2025

Accepted: 13 October 2025

First Online: 21 November 2025

Declarations

:

: The authors declare no competing interests.